Consumer Analyst Group of New York Conference (CAGNY) 2025 February 20, 2025 2:00 PM ETCompany ParticipantsLinda Rendle ...
Promising review: " Best, most affordable brush and sponge shampoo on the market! No joke, I have tried everything; even ...
Bring your home back to life after a long and lazy winter with tips on how to tackle a top-to-bottom household cleanup ...
(RTTNews) - While reporting its results for the second quarter, Clorox Company (CLX) lifted its earnings outlook for the full year. For the full year, the company now expects earnings to be ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Clorox (CLX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...
Dana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results